References and Notes
1a
Dolle RE.
J. Comb. Chem.
2001,
3:
477
1b
Hall DG.
Manku S.
Wang F.
J. Comb. Chem.
2001,
3:
125
1c
Booth S.
Hermkens PHH.
Ottenheijm HCJ.
Rees DC.
Tetrahedron
1998,
54:
15385
1d
Cowley PM.
Rees DC.
Cur. Med. Chem.
1997,
4:
211
1e
Thompson LA.
Ellman JA.
Chem. Rev.
1996,
96:
555
1f
Fruchtel JS.
Jung G.
Angew. Chem., Int. Ed. Engl.
1996,
35:
17
1g
Gordon EM.
Barrett RW.
Dower WJ.
Fodor SPA.
Gallop MA.
J. Med. Chem.
1994,
37:
1385
1h
Gallop MA.
Barrett RW.
Dower WJ.
Fodor SPA.
Gordon EM.
J. Med. Chem.
1994,
37:
1233
2a
Furka A.
Sebestyen F.
Asgedom M.
Dibo G.
Abstr. 14th Int. Congr. Biochem., Prague, Czechoslovakia
1988,
5:
47
2b
Furka A.
Sebestyen F.
Asgedom M.
Dibo G.
Abstr. 14th Int. Symp. Med. Chem., Budapest: Hungary
1988,
288
2c
Nicolaou KC.
Xiao X.-Y.
Parandoosh Z.
Senyei A.
Nova MP.
Angew. Chem., Int. Ed. Engl.
1995,
34:
2289
3a
Lou H.
Li X.
Onda M.
Konda Y.
Machida T.
Toda Y.
Harigaya Y.
J. Nat. Prod.
1993,
56:
1437
3b
Aimi N.
Hoshino H.
Nishimura M.
Sakai S.
Haginiwa J.
Tetrahedron Lett.
1990,
31:
5169
3c
Yoshikawa M.
Shimada H.
Nishida N.
Li Y.
Toguchida I.
Yamahara J.
Matsuda H.
Chem. Pharm. Bull.
1998,
46:
113
3d
Calis I.
Heilmann J.
Tasdemir D.
Linden A.
Ireland CM.
Sticher O.
J. Nat. Prod.
2001,
64:
961
3e
Li X.-C.
Jacob MR.
Pasco DS.
El Sohly HN.
Nimrod AC.
Walker LA.
Clark AM.
J. Nat. Prod.
2001,
64:
1282
4a
Demetzos C.
Skaltsounis A.-L.
Tillequin F.
Koch M.
Carbohydr. Res.
1990,
207:
131
4b
Kleine HP.
Weinberg DV.
Kaufman RJ.
Sidhu RS.
Carbohydr. Res.
1985,
142:
333
4c
Dess D.
Kleine HP.
Weinberg DV.
Kaufman RJ.
Synthesis
1981,
883
5a
Diedrich DF.
J. Med. Pharm. Chem.
1962,
5:
1054
5b
Konda Y.
Iwasaki Y.
Takahata S.
Arima S.
Toida T.
Kaji E.
Takeda K.
Harigaya Y.
Chem. Pharm. Bull.
1997,
45(4):
626
5c
Hongu M.
Saito K.
Tsujihara K.
Synth. Commun.
1999,
29:
2775
6
Gong Y.-D.
Yoo S.-E.
Bull. Korean Chem. Soc.
2001,
22(9):
941
7 ArgoGelΤ
Μ (Wang chloride resin) was purchased from Argonaut Technologies, San Carlos, CA.
8a
Uozumi Y.
Danjo H.
Hayashi T.
Tetrahedron Lett.
1997,
38:
3557
8b
Bayer E.
Rapp W.
Chemistry of Peptides and Proteins
Vol. 3:
Voelter W.
Bayer E.
Ovchinikov YA.
Iwanov VT.
Walter de Gruyter;
Berlin:
1986.
p.3
8c
Rapp W. In
Combinatorial Peptide and Nonpeptide Libraries
Jung G.
VCH;
Weilheim:
1996.
p.425
9a
O’Donnell MJ.
Zhou C.
Scott WL.
J. Am. Chem. Soc.
1996,
118:
6070
9b
O’Donnell MJ.
Delgado F.
Hostettler C.
Schwesinger R.
Tetrahedron Lett.
1998,
39:
8775
9c
O’Donnell MJ.
Drew MD.
Pottorf RS.
Scott WL.
J. Comb. Chem.
2000,
2:
172
10 Column: Mightysil RP-18 GP (ODS) 3 µm, 4.6 mmI. D. × 50 mm; mobile phase: 20 mM NH4OAc: MeOH = 70: 30 (0 min) Æ 10:90 (4 - 8 min); UV: 254 nm.
11
General Procedure for Glycosylation of Phenol Exemplified with the Synthesis of
m
-10: The resin m
-6 (4 × 30 mg, 0.17 mmol/g) was loaded into IRORIΤ
Μ MicroKans. To a solution of Cs2CO3 in THF-MeOH (1:1, 4 mL) was added the MicroKans at ambient temperature. After being shaked for 17 h at the same temperature, the reaction mixture was drained to isolate the Kans. The Kans were sequentially washed with DMF (4 × 5 mL), THF-water (2:1, 4 × 5 mL), 5% HOAc-THF (4 × 5 mL), THF (4 × 5 mL), MeOH (4 × 5 mL), and dichloromethane (DCM) (4 × 5 mL) and dried in vacuo to give immobilized phenol m
-7 in four Kans. Three MicroKans among them were exposed to a solution of glucosyl bromide 8a (463 mg) in 1,2-dichloroethane (4.2 mL). To the mixture were successively added 5% NaOH aq (2.1 mL), benzyl tri-n-butylammonium chloride (21.9 mg). After being shaked at ambient temperature for 15 h, the mixture was drained. Remaining three Kans were washed sequentially with DCM (5 mL), DMF (4 × 5 mL), THF-MeOH (1:1, 2 × 5 mL), 5% HOAc-THF (2 × 5 mL), THF (4 × 5 mL), MeOH (4 × 5 mL), and DCM (4 × 5 mL) and dried to give glycoside m
-9. The resin in the three MicroKans was cleaved with 10% TFA-DCM (5 mL) for 30 min. The resulting solution was diluted with DCM (5 mL) and toluene (2 mL). The MicroKans were removal from the solution by means of tweezers. The acidic solution was concentrated to afford m
-10 (9.8 mg, 0.014 mmol, 93%). Spectrum data of m
-10: 1H NMR (300 MHz, CDCl3): δ = 8.03 (2 H, dd, J = 1.2, 8.4 Hz), 7.99-7.90 (4 H, m), 7.86 (2 H, dd, J = 1.5, 8.4 Hz), 7.58-7.25 (13 H, m), 7.04-6.97 (1 H, m), 6.60-6.47 (3 H, m), 5.98 (1 H, dd, J = 9.4, 9.6 Hz), 5.79 (1 H, dd, J = 7.8, 9.4 Hz), 5.70 (1 H, dd, J = 9.4, 9.6 Hz), 5.37(1 H, d, J = 7.8 Hz), 4.68 (1 H, dd, J = 3.3, 12.3 Hz), 4.53 (1 H, dd, J = 6.3, 12.3Hz), 4.37-4.28 (1 H, m); MS (ESI): 706 [M + NH4
+].
12 Spectrum data, p
-10: 1H NMR (300 MHz, CDCl3): δ = 8.05-7.82 (8 H, m), 7.58-7.24 (13 H, m), 6.89 (2 H, d, J = 9.0 Hz), 6.61 (2 H, d, J = 9.0 Hz), 5.97 (1 H, dd, J = 9.6, 9.9 Hz), 5.76 (1 H, dd, J = 8.1, 9.9 Hz), 5.70 (1 H, dd, J = 9.6, 9.9 Hz), 5.26 (1 H, d, J = 8.1 Hz), 4.66 (1 H, dd, J = 3.0, 12.3 Hz), 4.53 (1 H, dd, J = 6.3, 12.3 Hz), 4.30-4.23 (1 H, m); MS (ESI): 706 [M + NH4
+].
13a Review: McKee FW.
Hawkins WB.
Physiol. Rev.
1945,
25:
255
13b
Alvarado F.
Crane RK.
Physiol. Rev.
1964,
93:
116
13c
Toggenburger G.
Kessler M.
Semenza G.
Physiol. Rev.
1982,
688:
557
14
Miles CO.
Main L.
Nicholson BK.
Aust. J. Chem.
1989,
42:
1103
15 Spectrum data, 18a: 1H NMR (300 MHz, CDCl3): δ = 12.99 (1 H, s), 7.99 (2 H, d, J = 8.0 Hz), 7.96-7.89 (4 H, m), 7.84 (2 H, d, J = 8.0 Hz), 7.60-7.24 (12 H, m), 7.10 (1 H, dd, J = 8.1, 8.4 Hz), 6.61 (1 H, d, J = 8.4 Hz), 6.56 (1 H, d, J = 8.1 Hz), 6.03 (1 H, dd, J = 9.6, 10.0 Hz), 5.92 (1 H, dd, J = 7.5, 9.6 Hz), 5.74 (1 H, dd, J = 9.6, 10.0 Hz), 5.63 (1 H, d, J = 7.5 Hz), 4.68 (1 H, dd, J = 2.7, 13.2 Hz), 4.52 (1 H, dd, J = 7.8, 13.2 Hz), 4.42-4.33 (1 H, m), 2.61 (3 H, s); MS (ESI): 748 [M + NH4
+]. 18b: 1H NMR (300 MHz, CDCl3): δ = 13.00 (1 H, s), 8.09 (2 H, dd, J = 1.5, 8.4 Hz), 8.03 (2 H, dd, J = 1.5, 8.4 Hz), 7.91 (2 H, dd, J = 1.5, 8.7 Hz), 7.81 (2 H, dd, J = 1.5, 8.7 Hz), 7.68-7.23 (12 H, m), 7.10 (1 H, dd, J = 7.5, 8.4 Hz), 6.63 (1 H, d, J = 7.5 Hz), 6.60 (1 H, d, J = 8.4 Hz), 6.17 (1 H, dd, J = 8.1, 10.2 Hz), 6.07 (1 H, d, J = 3.3 Hz), 5.71 (1 H, dd, J = 3.3, 10.2 Hz), 5.62 (1 H, d, J = 8.1 Hz), 4.67-4.50 (3 H, m), 2.65 (3 H, s); MS (ESI): 748 [M + NH4
+]. 18c: 1H NMR (300 MHz, CDCl3): δ = 12.97 (1 H, s), 8.03 (2 H, d, J = 6.9 Hz), 7.99-7.88 (4 H, m), 7.61-7.30 (10 H, m), 6.68 (2 H, dd, J = 2.0, 8.4 Hz), 5.92 (1 H, dd, J = 7.5, 7.8 Hz), 5.77 (1 H, dd, J = 5.7, 7.8 Hz), 5.64 (1 H, d, J = 5.7 Hz), 5.49-5.40 (1 H, m), 4.53 (1 H, dd, J = 3.5, 13.2 Hz), 3.89 (1 H, dd, J = 8.0, 13.2 Hz), 2.62 (3 H, s); MS (ESI): 614 [M + NH4
+]. 18d: 1H NMR (300 MHz, CDCl3): δ = 12.97 (1 H, s), 8.06 (2 H, dd, J = 1.5, 8.4 Hz), 7.98 (2 H, dd, J = 1.5, 8.7 Hz), 7.91 (2 H, dd, J = 1.2, 8.4 Hz), 7.65-7.25 (10 H, m), 6.69 (1 H, d, J = 8.4 Hz), 6.67 (1 H, d, J = 8.4 Hz), 6.09 (1 H, dd, J = 6.6, 9.0 Hz), 5.81-5.75 (1 H, m), 5.71 (1 H, dd, J = 3.3, 9.0 Hz), 5.58 (1 H, d, J = 6.6 Hz), 4.43 (1 H, dd, J = 3.9, 13.2 Hz), 4.08 (1 H, dd, J = 2.0, 13.2 Hz), 2.66 (3 H, s); MS (ESI): 614 [M + NH4
+].